Picture EBD Group World of Partnering Opportunities 650x100px
Organisation › Details

TreeFrog Therapeutics SAS

TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients. TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-StemTM technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality. Bringing together over 80 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M over the past 3 years to advance its pipeline of stem cell-based therapies in the field of neurodegeneration, cardio-metabolic disorders, and immuno-oncology. The company is currently opening technological hubs in Boston, USA, and Kobe, Japan, to drive the adoption of C-StemTM and initiate co-development partnerships with leading academic, biotech and industry players in the field of cell therapy. Since 2018, TreeFrog Therapeutics has been actively participating to the Japanese Society for Regenerative Medicine and the Link-J consortium, and is a Supporting Member of the CiRA Foundation. In 2020, TreeFrog Therapeutics launched a collaboration on iPSC quality with the Foundation for Biomedical Research and Innovation at Kobe (FBRI) and the Harvard Stem Cell Institute, which was awarded by the prestigious Prix Galien MedStartup Prize in New York. *


Period Start 2018-12-07 established
  Group TreeFrog Therapeutics (Group)
Products Industry C-Stem™ technology platform (based on 3D stem cell culture)
  Industry 2 stem cell therapy
Persons Person Desdouits, Frédéric (TreeFrog Therapeutics 202109– CEO before PCAS + Seqens + Pierre Fabre + Bionest Partners)
  Person 2 Alessandri, Kévin (TreeFrog Therapeutics 202201– Managing Director TreeFrog Tx Inc before CEO + CTO + Co-Founder)
Region Region Bordeaux
  Country France
  Street 30 avenue Gustave Eiffel
Bât A
  City 33600 Pessac (Bordeaux)
  Tel +33-7-6259-7498
    Address record changed: 2024-01-05
Basic data Employees B: 11 to 50 (2021-09-13)
    * Document for »About Section«: TreeFrog Therapeutics SAS. (4/8/22). "Press Release: TreeFrog Therapeutics Opens Technological Hub in Kobe, Japan, to Drive Partnerships Opportunities in the Field of iPSC-derived Cell Therapies". Kobe.
Record changed: 2024-06-07


Picture Berlin Partner Top News Captain T Cell Therapies 650x200px

More documents for TreeFrog Therapeutics (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group World of Partnering Opportunities 650x300px

» top